The Role of Surgery for Oligometastatic Non-Small Cell Lung Cancer

被引:3
|
作者
Euhus, Caleb J. [1 ]
Ripley, Taylor R. [1 ]
Medina, Cristian G. [1 ]
机构
[1] Baylor Coll Med, Michael E DeBakey Dept Surg, Div Thorac Surg, 1 Moursund St, Houston, TX 77030 USA
关键词
oligometastatic non-small cell lung cancer; metastatic non-small cell lung cancer; NSCLC history; lung cancer staging; surgery and NSCLC; local consolidative therapy (LCT); locally-aggressive therapy (LAT); LONG-TERM SURVIVAL; PROGNOSTIC-FACTORS; THERAPY; RADIOTHERAPY; CLASSIFICATION; MULTICENTER; PROGRESSION; METASTASIS; MANAGEMENT; RESECTION;
D O I
10.3390/cancers14102524
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Simple Summary This article clarifies the context and definition of the term oligometastasis as it applies to non-small cell lung cancer and reviews the current results in the use of surgery for its management. Ideally after reading this article, practitioners will be better equipped to pick patients for locally aggressive therapy, and researchers will be primed to design the next generation of studies that prioritize treatments in the management of this historically deadly disease. Oligometastatic non-small cell lung cancer (NSCLC) is metastatic disease that refers to a limited number of metastatic sites. It is analogous to an intermediate stage of NSCLC, between localized and widely metastatic disease, even though no staging criteria establishes this distinction. Oligometastatic NSCLC describes a patient subgroup with limited metastasis to one or a few organs. These patients seem to have a more indolent cancer than those with diffuse metastasis. For these select patients with oligometastatic disease, the use of palliative systemic therapy over local aggressive treatment may be a missed opportunity to improve survival. The clear definition of this subgroup and identification of the best treatment remains the current challenge in the management of the disease. Surgery was the early cornerstone in the treatment of limited disease; however, as modalities such as chemotherapy, stereotactic radiosurgery, and immunotherapy have matured, the role of excision is less clearly defined. There are sparse randomized controlled trials comparing the efficacy of different treatment modalities in patients with oligometastatic NSCLC. However, there is a growing body of retrospective research detailing the prognostic factors that characterize the role of surgery in the management of these patients. This article clarifies the context and definition of the term oligometastatic, as it applies to NSCLC, and reviews the current results in the use of surgery for its management.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] Multimodal treatment of oligometastatic non-small cell lung cancer
    Graca, Luis Lourenco
    Pego, Alice
    Lareiro, Susana
    Pancas, Rita
    BMJ CASE REPORTS, 2023, 16 (12)
  • [22] Surgical approach in oligometastatic non-small cell lung cancer
    Patrini, Davide
    Panagiotopoulos, Nikolaos
    Bedetti, Benedetta
    Mitsos, Sofoklis
    Crisci, Roberto
    Solli, Piergiorgio
    Bertolaccini, Luca
    Scarci, Marco
    ANNALS OF TRANSLATIONAL MEDICINE, 2018, 6 (05)
  • [23] THE ROLE OF SURGERY IN NON-SMALL CELL LUNG-CANCER
    WATSON, DCT
    BRITISH JOURNAL OF CANCER, 1987, 56 (06) : 885 - 886
  • [24] Oligometastatic Non-Small Cell Lung Cancer: The Pivotal Role of Nodal Status Reply
    Toennies, Mario
    Pfannschmidt, Joachim
    Bauer, Torsten T.
    Kollmeier, Jens
    Toennies, Sabine
    Kaiser, Dirk
    ANNALS OF THORACIC SURGERY, 2014, 98 (04): : 1526 - 1527
  • [25] The role of the surgeon in the management of oligometastatic non-small cell lung cancer: a literature review
    Berzenji, Lawek
    Debaenst, Sophie
    Hendriks, Jeroen M. H.
    Yogeswaran, Suresh Krishan
    Lauwers, Patrick
    Van Schil, Paul E.
    TRANSLATIONAL LUNG CANCER RESEARCH, 2021, 10 (07) : 3409 - 3419
  • [26] LOCAL TREATMENT OF OLIGOMETASTATIC RECURRENCE AFTER SURGERY FOR NON-SMALL CELL LUNG CANCER.
    Yano, Tokujiro
    Okamoto, Tatsuro
    Haro, Akira
    Fukuyama, Seiichi
    Kawano, Daigo
    Morodomi, Yosuke
    Yoshida, Tsukihisa
    Kohno, Mikihiro
    Maehara, Yoshihiko
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S392 - S392
  • [27] Surgical Treatment of Extrapulmonary Oligometastatic Non-small Cell Lung Cancer
    Ploenes, Till
    Osei-Agyemang, Thomas
    Krohn, Alexander
    Passlick, Bernward
    INDIAN JOURNAL OF SURGERY, 2015, 77 : S216 - S220
  • [28] Management of Oligometastatic Disease in Advanced Non-Small Cell Lung Cancer
    West, Howard
    CLINICS IN CHEST MEDICINE, 2020, 41 (02) : 249 - +
  • [29] The current state of oligometastatic and oligoprogressive non-small cell lung cancer
    Tumati, Vasu
    Iyengar, Puneeth
    JOURNAL OF THORACIC DISEASE, 2018, 10 : S2537 - S2544
  • [30] Management of Synchronous Extrathoracic Oligometastatic Non-Small Cell Lung Cancer
    Jones, Gregory D.
    Lengel, Harry B.
    Hsu, Meier
    Tan, Kay See
    Caso, Raul
    Ghanie, Amanda
    Connolly, James G.
    Bains, Manjit S.
    Rusch, Valerie W.
    Huang, James
    Park, Bernard J.
    Gomez, Daniel R.
    Jones, David R.
    Rocco, Gaetano
    CANCERS, 2021, 13 (08)